Semax (10mg)

Semax is a heptapeptide originally developed in Russia, structurally derived from a fragment of adrenocorticotropic hormone (ACTH). It is referenced in laboratory research investigating BDNF expression, neuroprotection, and cognitive-function pathways in pre-clinical models.

Supplied as 10mg of lyophilised powder per vial, intended for reconstitution and research use only.

Strictly for laboratory research use. Not approved for human or animal use.